ARGX FY 2023 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena

ARGXargenx SE

$46B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.2B+198.6% YoY

Gross Profit

$1.1B90.4% margin

Operating Income

-$425M-34.7% margin

Net Income

-$295M-24.1% margin

EPS (Diluted)

$-5.16

Cash Flow

Operating Cash Flow

-$420M

Free Cash Flow

-$464M

Stock-Based Comp.

$233M

Balance Sheet

Total Assets

$4.5B

Total Liabilities

$445M

Stockholders' Equity

$4.1B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$411M	+198.6%
Gross Profit	$1.1B	$381M	+190.7%
Operating Income	-$425M	-$720M	+41.0%
Net Income	-$295M	-$710M	+58.4%